GeneDx Holdings Corp. (WGS)
NASDAQ · Healthcare
GeneDx Holdings Corp. annual/quarterly long term debt history from 2020 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- GeneDx Holdings Corp. long term debt for the quarter ending December 31, 2025 were 54.5M, a 2.17% decrease year-over-year.
- GeneDx Holdings Corp. long term debt for 2025 were 54.5M, a 2.17% decrease from 2024.
- GeneDx Holdings Corp. long term debt for 2024 were 55.8M, a 0.88% decrease from 2023.
- GeneDx Holdings Corp. long term debt for 2023 were 56.3M, a 411.36% increase from 2022.
- GeneDx Holdings Corp. long term debt for 2022 were 11.0M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| GeneDx Holdings Corp. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $55 |
| 2024 | $56 |
| 2023 | $56 |
| 2022 | $11 |
| 2021 | $11 |
| 2020 | $19 |
| GeneDx Holdings Corp. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $55 |
| 2024-12-31 | $56 |
| 2023-12-31 | $56 |
| 2022-12-31 | $11 |
| 2021-12-31 | $11 |
| 2020-12-31 | $19 |
GeneDx Holdings Corp. Long Term Debt — FAQ
GeneDx Holdings Corp. (WGS) long term debt over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see WGS's long term debt history?
The chart and table above show GeneDx Holdings Corp.'s long term debt by year and by quarter, including the growth rate.